Skip to main content

PAS 2022 Main banner

Tweets by PAS 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Marissa Wilck, MD photo

Marissa Wilck, MD

Clinical Director
Merck & Co., Inc.

Poster(s):

553 - Safety and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Children Living with HIV: A Phase 3 Trial (PNEU-WAY PED)
Sunday, April 24, 2022
3:30 PM – 6:00 PM US MT